
    
      This is a prospective, multi-center, randomized, double-blind, placebo-controlled study of
      the safety and efficacy of NH001 to improve the functional outcome of patients in a
      vegetative state or minimally conscious state following a severe traumatic brain injury
      (TBI).
    
  